Public health risks of approving drugs for the treatment of childhood obesity in Brazil.

IF 1.9 4区医学 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Cadernos de saude publica Pub Date : 2024-09-20 eCollection Date: 2024-01-01 DOI:10.1590/0102-311XEN031624

Márcia Regina Vítolo, Paola Seffrin Baratto, Sophie Deram

引用次数: 0

查看原文本刊更多论文

巴西批准治疗儿童肥胖症药物的公共卫生风险。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cadernos de saude publica 医学-公共卫生、环境卫生与职业卫生

CiteScore

5.30

自引率

7.10%

发文量

356

审稿时长

3-6 weeks

期刊介绍： Cadernos de Saúde Pública/Reports in Public Health (CSP) is a monthly journal published by the Sergio Arouca National School of Public Health, Oswaldo Cruz Foundation (ENSP/FIOCRUZ). The journal is devoted to the publication of scientific articles focusing on the production of knowledge in Public Health. CSP also aims to foster critical reflection and debate on current themes related to public policies and factors that impact populations'' living conditions and health care. All articles submitted to CSP are judiciously evaluated by the Editorial Board, composed of the Editors-in-Chief and Associate Editors, respecting the diversity of approaches, objects, and methods of the different disciplines characterizing the field of Public Health. Originality, relevance, and methodological rigor are the principal characteristics considered in the editorial evaluation. The article evaluation system practiced by CSP consists of two stages.